These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32357147)

  • 61. Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index.
    Johnson SI; Fort D; Shortt KJ; Therapondos G; Galliano GE; Nguyen T; Bluth EI
    Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441377
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis.
    Webb M; Yeshua H; Zelber-Sagi S; Santo E; Brazowski E; Halpern Z; Oren R
    AJR Am J Roentgenol; 2009 Apr; 192(4):909-14. PubMed ID: 19304694
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study.
    Perez NE; Siddiqui FA; Mutchnick MG; Dhar R; Tobi M; Ullah N; Saksouk FA; Wheeler DE; Ehrinpreis MN
    J Clin Gastroenterol; 2007 Jul; 41(6):624-9. PubMed ID: 17577120
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis.
    Marshall RH; Eissa M; Bluth EI; Gulotta PM; Davis NK
    AJR Am J Roentgenol; 2012 Nov; 199(5):997-1002. PubMed ID: 23096171
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis.
    Borges VF; Diniz AL; Cotrim HP; Rocha HL; Andrade NB
    J Clin Ultrasound; 2013 Jan; 41(1):18-25. PubMed ID: 22997020
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Utility of Ultrasound-Guided Attenuation Parameter for the Detection and Quantification of Hepatic Steatosis in Patients with Fatty Liver Diagnosed by Computed Tomography.
    Iwashita H; Shakado S; Yoshimaru N; Tanaka H; Koto F; Tanaka T; Takata K; Yokoyama K; Yamaguchi M; Irie M; Hirai F
    Ultrasound Med Biol; 2022 Jul; 48(7):1282-1289. PubMed ID: 35397929
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability.
    Jesper D; Klett D; Schellhaas B; Pfeifer L; Leppkes M; Waldner M; Neurath MF; Strobel D
    IEEE J Transl Eng Health Med; 2020; 8():1800409. PubMed ID: 32617199
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan].
    Xu L; Li P; Lu W; Shi Q; Shi R; Zhang X; Liu Y; Wang Q; Fan J; Mi Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):108-13. PubMed ID: 26983477
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy.
    Williamson RM; Perry E; Glancy S; Marshall I; Gray C; Nee LD; Hayes PC; Forbes S; Frier BM; Johnston GI; Lee AJ; Reynolds RM; Price JF; Strachan MW;
    Clin Radiol; 2011 May; 66(5):434-9. PubMed ID: 21345425
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study.
    Hepburn MJ; Vos JA; Fillman EP; Lawitz EJ
    BMC Gastroenterol; 2005 Apr; 5():14. PubMed ID: 15829009
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Targher G; Lonardo A
    Metabolism; 2017 Jul; 72():57-65. PubMed ID: 28641784
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Computerized ultrasound image analysis for noninvasive evaluation of hepatic steatosis.
    Nagy G; Munteanu M; Gordan M; Chira R; Iancu M; Crisan D; Mircea PA
    Med Ultrason; 2015 Dec; 17(4):431-6. PubMed ID: 26649335
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease.
    Lee HA; Kim SS; Choi JY; Seo YS; Park BJ; Sim KC; Kim SU
    Abdom Radiol (NY); 2022 Nov; 47(11):3733-3745. PubMed ID: 35962809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The accuracy of sonography in predicting steatosis and fibrosis in chronic hepatitis C.
    Chen CH; Lin ST; Yang CC; Yeh YH; Kuo CL; Nien CK
    Dig Dis Sci; 2008 Jun; 53(6):1699-706. PubMed ID: 17939048
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B.
    Kelly EM; Feldstein VA; Etheridge D; Hudock R; Peters MG
    J Ultrasound Med; 2017 May; 36(5):925-932. PubMed ID: 28151547
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.
    Schneider AR; Teuber G; Kriener S; Caspary WF
    Liver Int; 2005 Dec; 25(6):1150-5. PubMed ID: 16343065
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.
    Andrade P; Rodrigues S; Rodrigues-Pinto E; Gaspar R; Lopes J; Lopes S; Macedo G
    GE Port J Gastroenterol; 2017 Jul; 24(4):161-168. PubMed ID: 29255745
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease.
    Jung KS; Kim BK; Kim SU; Chon YE; Chun KH; Kim SB; Lee SH; Ahn SS; Park JY; Kim DY; Ahn SH; Park YN; Han KH
    PLoS One; 2014; 9(6):e98689. PubMed ID: 24901649
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Correlation between hepatorenal index and attenuation imaging for assessing hepatic steatosis.
    Srigandan S; Zelesco M; Abbott S; Welman CJ
    Australas J Ultrasound Med; 2022 Aug; 25(3):107-115. PubMed ID: 35978731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.